Login / Signup

A Randomized, Double-Blind, Placebo-Controlled, Multicentric Study to Evaluate the Efficacy and the Tolerability of a Class II Medical Device in the Treatment of Mild and Moderate Acne.

Gabriella FabbrociniMaria FerrilloMarianna DonnarummaAngela PapaleDaniela PintoFabio Rinaldi
Published in: Dermatology and therapy (2022)
It was observed that the participants showed an overall improvement of the analyzed lesions in comparison with the placebo group, without adverse events during the trial. Hence, the medical device was found to be safe and effective in the treatment of mild or moderate acne.
Keyphrases
  • placebo controlled
  • double blind
  • phase iii
  • clinical trial
  • healthcare
  • study protocol
  • phase ii
  • open label
  • high intensity
  • randomized controlled trial
  • radiation therapy
  • replacement therapy
  • clinical evaluation